BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Treatment
103 results:

  • 1. Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer.
    Cho BC; Chiu CH; Massarelli E; Buchschacher GL; Goto K; Overbeck TR; Loong HHF; Chee CE; Garrido P; Dong X; Fan Y; Lu S; Schwemmers S; Bordogna W; Zeuner H; Osborne S; John T
    Lung Cancer; 2024 Feb; 188():107442. PubMed ID: 38171156
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis.
    Zhao J; Zhang S; Guo X; Li C; Yang B; Qu X; Wang S
    BMC Cancer; 2023 Dec; 23(1):1221. PubMed ID: 38082441
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Use of 18F-FDG PET/MRI as an Initial Staging Procedure for Nasopharyngeal Carcinoma.
    Cao C; Fang Y; Yu B; Xu Y; Qiang M; Tao C; Huang S; Chen X
    J Magn Reson Imaging; 2024 Mar; 59(3):922-928. PubMed ID: 37256732
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Real-time in vivo cancer staging of nasopharyngeal carcinoma patients with rapid fiberoptic Raman endoscopy.
    Shu C; Zheng W; Lin K; Lim CM; Huang Z
    Talanta; 2023 Jul; 259():124561. PubMed ID: 37080076
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [A Case of Specific Pneumonia Diagnosed as Peritumoral Infiltration during Nivolumab treatment for Esophageal cancer].
    Sasaki N; Miura A; Suzuki K; Haruki S; Yamaguchi K
    Gan To Kagaku Ryoho; 2023 Apr; 50(4):526-528. PubMed ID: 37066476
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [A Case of Esophageal cancer with Consciousness Disorder Due to Hyperammonemia during FP treatment].
    Yamasaki Y; Ryotokuji T; Matsui T; Miura T; Chiba T; Hayashi M; Yokosuka T; Noguchi N; Tsunemi A; Iseki H
    Gan To Kagaku Ryoho; 2023 Apr; 50(4):493-495. PubMed ID: 37066465
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line treatment for Advanced Esophageal cancer: A US Healthcare Payer's Perspective.
    Qu T; Zhang S; Zhong Y; Meng Y; Guo H; Joo S; Enzinger PC
    Pharmacoeconomics; 2022 Dec; 40(12):1247-1259. PubMed ID: 36241842
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of Efficacy and Safety of Taxanes Plus Platinum and Fluorouracil Plus Platinum in the First-Line treatment of Esophageal cancer: A Systematic Review and Meta-Analysis.
    Zhao Y; Song R; Jia Y; Zhang X; Zhang S; Wu C; Zhang R; Guo Z
    Curr Oncol; 2022 Sep; 29(9):6610-6627. PubMed ID: 36135088
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. How can counselling by family physicians on nutrition and physical activity be improved: trends from a survey in Germany.
    Boesenecker SJ; Mathies V; Buentzel J; Huebner J
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3335-3347. PubMed ID: 35932301
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical significance of tumor chemosensitivity assay in patients with head and neck cancer].
    Liu K; Gu X; Chen N; You W; Wei J; Ma L; Zhang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Mar; 36(3):205-211. PubMed ID: 35193343
    [No Abstract]    [Full Text] [Related]  

  • 11. [A Case of Combined Modality Therapy for Progressive Esophagus cancer with Perforation Due to Preoperative Chemotherapy].
    Miyoshi K; Ota Y; Sakurai T; Matsumoto M; Yamada E; Enomoto M; Iwasaki K; Nagakawa Y; Katsumata K; Tsuchida A
    Gan To Kagaku Ryoho; 2022 Jan; 49(1):77-79. PubMed ID: 35046367
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A comparison of two methodologies for radiotherapy treatment plan optimization and QA for clinical trials.
    Geng H; Giaddui T; Cheng C; Zhong H; Ryu S; Liao Z; Yin FF; Gillin M; Mohan R; Xiao Y
    J Appl Clin Med Phys; 2021 Oct; 22(10):329-337. PubMed ID: 34432946
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Deep Learning-Guided Fiberoptic Raman Spectroscopy Enables Real-Time
    Shu C; Yan H; Zheng W; Lin K; James A; Selvarajan S; Lim CM; Huang Z
    Anal Chem; 2021 Aug; 93(31):10898-10906. PubMed ID: 34319713
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma.
    Nakaya S; Ogawa R; Hayakawa S; Fujihata S; Okubo T; Sagawa H; Tanaka T; Takahashi H; Matsuo Y; Takiguchi S
    World J Surg Oncol; 2021 Jul; 19(1):217. PubMed ID: 34281546
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50.
    Greenberg SE; Holman R; Kohlmann W; Buchmann L; Naumer A
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):447-452. PubMed ID: 34255389
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Raltitrexed versus 5-fluorouracil with cisplatin and concurrent radiotherapy for locally advanced nasopharyngeal carcinoma: An open labeled, randomized, controlled, and multicenter clinical trial.
    Yan P; Yin H; Guo W; Sun X; Li F; Huang S; Bian X; Wang F; Zhang F; Wang B; Zhou H; Zhou C; Yin L; Jiang X; Jiang N; Wu J; Liu J; Song D; He X
    Cancer Med; 2020 Sep; 9(17):6166-6172. PubMed ID: 32657029
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Changing Paradigm of head and neck Paragangliomas: What Every Otolaryngologist Needs to Know.
    Cass ND; Schopper MA; Lubin JA; Fishbein L; Gubbels SP
    Ann Otol Rhinol Laryngol; 2020 Nov; 129(11):1135-1143. PubMed ID: 32486832
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. DPD status and fluoropyrimidines-based treatment: high activity matters too.
    Chamorey E; Francois E; Etienne MC; Ferrero JM; Peyrade F; Barranger E; Bozec A; Largillier R; Cassuto O; Viotti J; Schiappa R; Milano G
    BMC Cancer; 2020 May; 20(1):436. PubMed ID: 32423482
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [A Case of Local Remnant Esophageal cancer after Chemotherapy Getting Complete Response by Radiotherapy].
    Takahashi K; Sato S; Ota Y; Watanabe T; Tachibana S; Suda T; Makuuchi Y; Iwasaki K; Nagakawa Y; Osaka Y; Seshimo A; Katsumata K; Tsuchida A
    Gan To Kagaku Ryoho; 2020 Mar; 47(3):510-512. PubMed ID: 32381932
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Neoadjuvant Triplet Combination Chemotherapy(UDON Therapy)in Esophageal cancer Patients with Impaired Renal Function-A Retrospective Study].
    Kimura Y; Shiraishi O; Iwama M; Kato H; Kawakami H; Okuno T; Hiraki Y; Yasuda A; Shinkai M; Imano M; Nakagawa K; Yasuda T
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2173-2175. PubMed ID: 32156869
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.